CTLT Catalent Inc

USD 56.45 -0.03 -0.053116
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Under-perform

Average User
Rating

USD 56.45

-0.03 (-0.05)%

USD 10.16B

1.84M

USD 55.67(-1.39%)

USD 84.67 (+49.99%)

Icon

CTLT

Catalent Inc (USD)
COMMON STOCK | NYE
USD 56.45
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Under-perform

Average User
Rating

USD 10.16B

USD 84.67 (+49.99%)

USD 56.45

Catalent Inc (CTLT) Stock Forecast

USD 55.67
(-1.39%)

Based on the Catalent Inc stock forecast from 6 analysts, the average analyst target price for Catalent Inc is USD 55.67 over the next 12 months. Catalent Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Catalent Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Catalent Inc’s stock price was USD 56.45. Catalent Inc’s stock price has changed by +1.07% over the past week, -2.57% over the past month and -14.37% over the last year.

No recent analyst target price found for Catalent Inc
No recent average analyst rating found for Catalent Inc

Company Overview Catalent Inc

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment p...Read More

https://www.catalent.com

14 Schoolhouse Road, Somerset, NJ, United States, 08873

18,000

June

USD

USA

Adjusted Closing Price for Catalent Inc (CTLT)

Loading...

Unadjusted Closing Price for Catalent Inc (CTLT)

Loading...

Share Trading Volume for Catalent Inc Shares

Loading...

Compare Performance of Catalent Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CTLT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Catalent Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc +0.70 (+0.42%) USD79.01B 34.04 22.84

ETFs Containing CTLT

Symbol Name CTLT's Weight Expense Ratio Price(Change) Market Cap
DOCG:LSE
L&G Healthcare Breakthrou.. 2.20 % 0.49 % +6.50 (+0.71%) USD0.08B

Frequently Asked Questions About Catalent Inc (CTLT) Stock

Based on ratings from 6 analysts Catalent Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and 7 hold ratings.

Unfortunately we do not have enough data on CTLT's stock to indicate if its a good dividend stock.

Based on targets from 6 analysts, the average taret price for CTLT is USD 55.67 over the next 12 months. The maximum analyst target price is USD 63.5 while the minimum anlayst target price is USD 42.

CTLT stock's Price/Earning ratio is 211.02. Our analysis grades CTLT stock's Price / Earning ratio at F. This means that CTLT stock's Price/Earning ratio is above 89% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this CTLT may be a overvalued for its sector.

The last closing price of CTLT's stock was USD 56.45.

The most recent market capitalization for CTLT is USD 10.16B.

Based on targets from 6 analysts, the average taret price for CTLT is projected at USD 55.67 over the next 12 months. This means that CTLT's stock price may go down by -1.39% over the next 12 months.

Following are ETFs with the highest allocation to Catalent Inc's stock :

DOCG:LSE

As per our most recent records Catalent Inc has 18,000 Employees.

Catalent Inc's registered address is 14 Schoolhouse Road, Somerset, NJ, United States, 08873. You can get more information about it from Catalent Inc's website at https://www.catalent.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...